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Purpose: Iliac vein occlusive disease leads to 73% of rethrombosis that occurs after venous thrombectomy when left
untreated. The goal of this study is to present our long-term results of stenting of iliocaval occlusive lesions persisting
after surgical venous thrombectomy.
Methods: From November 1995 to April 2007, 29 patients (19 women), with a median age of 38 years, had surgical
venous thrombectomy with creation of an arteriovenous fistula and angioplasty and stenting. All were admitted for acute
(<10 days) deep venous thrombosis (DVT) involving the iliocaval segment, of which eight had concomitant acute
pulmonary embolism. Six patients had a history of DVT (2 with previous venous thrombectomy), two were pregnant, and
three had postpartum DVT. No patients had short- or mid-term life-threatening factors. The underlying lesion was left
iliocaval compression (May-Thurner syndrome) in 22 patients, chronic left common iliac vein occlusion in 3, residual clot
in 3, and compression of the left external iliac vein by the left internal iliac artery in 1.
Results: Neither perioperative death nor pulmonary embolism occurred. Four early complications occurred after stenting
(13.8%). Median hospital length of stay was 8 days (range, 5-22 days). Median follow-up was 63 months (range, 2-137
months). Three late complications occurred (10.3 %): one rethrombosis due to stent crushing during pregnancy and two
restenosis, which were treated by iterative stenting. At the end of the follow-up, the median venous clinical severity score
was 3 (range 1-12) and the venous disability score was 1 (range 0-2). Primary, assisted primary and secondary patency
rates were, respectively, 79%, 86%, and 86% at 12, 60, and 120 months. Patients with patent iliocaval segments had
significantly fewer infrainguinal obstructive lesions (4% vs 50%) and a higher rate of valvular competence (76% vs 0%) than
those who experienced rethrombosis. Venous scores were also worse in patients with rethrombosis.
Conclusion: Stenting is a safe, efficient, and durable technique to treat occlusive iliocaval disease after venous thrombec-
tomy. Its use can prevent most of the rethrombosis that occurrs after venous thrombectomy without major adverse
effects. ( J Vasc Surg 2008;47:381-7.)Deep venous thrombosis (DVT) is a challenging situa-
tion. Its treatment should prevent thrombus extension,
pulmonary embolism, and long-term venous insufficiency.
Although medical treatment achieves prevention of the first
two goals, it does not prevent long-term complications,
mainly in cases of iliocaval extension of the thrombus.
Ziegler et al1 showed that at a mean follow-up of 6 years
after the onset of DVT, 82% of the patients presented with
post-thrombotic syndrome.
Venous thrombectomy was first proposed by Läwen in
1938.2 Its results were improved by some refinements, such
as the arteriovenous fistula (AVF) proposed by Kunlin to
prevent rethrombosis or the use of a positive end-expiration
pressure (PEEP) to prevent pulmonary embolism. We have
shown that this technique is safe and associated with good
long-term results in term of patency, femoropopliteal valves
competence, and freedom of ulceration.3 However, one of
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doi:10.1016/j.jvs.2007.10.007the main concerns with this technique was early rethrom-
bosis. Similar to Mickley et al,4 we found that iliac vein
occlusive lesions left untreated were the first cause of re-
thrombosis. Stenting is certainly a less invasive way to treat
these lesions, and we began to use it in 1995.5 The goal of
this study is to report our late results and to compare them
with the literature.
MATERIAL AND METHODS
From November 1995 to March 2007, 35 venous
thrombectomies were performed in our department. This
technique is indicated in our department for acute and
proximal (iliofemoral with or without inferior vena cava
[IVC] involvement) DVT. This means that3:
● The thrombosis should be 7 days old. Estimation of
the age of the thrombus is given by the onset of the
first symptoms. The characteristics of the clot at duplex
ultrasound (DUS) scan (hypoechogenic and nonad-
herent clot with dilatation of the vein) and computed
tomography (CT) scan (hypodense clot with periph-
eral enhancement and vein dilatation; Fig 1, A; Fig 2,
B) can help to confirm this.
● The common femoral vein should be completely oc-
cluded.
● Patients should be in good condition, with a life ex-
pectancy of at least 5 years, and they should not have
cancer, sepsis, inflammatory disease by CT scan, or
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to be ambulatory the day after the procedure (patients
with severe polytrauma, major neurologic deficit, etc.
were not considered for venous thrombectomy).
● Pregnancy, postdelivery, and thrombolytic treatment
failure are not a contraindication to venous thromb-
ectomy.
The study population comprised 29 patients (19
women), with a median age 38 years (range, 19-72 years),
who had iliocaval stenting associated with the surgical
thrombectomy. The six earlier cases were already published
in previous reports.5,6
Six patients had a history of DVT, including two that
had been surgically treated: one had a left iliofemoral
venous thrombectomy 24 years before, and one had a left
iliofemoral and IVC venous thrombectomy with placement
of an IVC clip 14 years before (Fig 2).
Among the 19 women, 12 had history of pregnancy,
including three who were postpartum, and two who were
pregnant. Five women were taking oral contraception. One
patient had retroperitoneal fibrosis, one had Cacchi and
Ricci disease with JJ catheter insertion 10 days earlier, and
four had trauma 15 days of the onset of the symptoms.
Eleven patients (37.9%) had a contraindication for throm-
Fig 1. Acute left femoroiliac deep vein thrombosis w
tomography angiography shows a stenosis of the left co
parietal enhancement; the inferior vena cava is free. B, An
tight stenosis of the distal left common iliac vein and t
angiography after angioplasty and stenting.
Fig 2. Acute biiliocaval thrombosis in a patient with pr
associated with insertion of an inferior vena cava clip. A,
of the clip. B, In this CTA scan of the proximal inferior
contrast enhancement. C, Angiography after venous thro
and thromboaspiration of the inferior vena cava shows
iterative thromboaspiration and angioplasty and stentingbolysis.Median American Society of Anesthesiologists (ASA)7
score was 1 (range, 1-3). The only ASA 3 patient was a
72-year-old man who had no other pathology and was still
alive 76 months after the procedure.
All patients were tested for thrombophilia, and a pro-
thrombotic state was found in 10 (Table I). No anomaly
was found in a patient with a personal and large familial
history of DVT.
Median duration of DVT since symptoms onset was 3
days (range, 1-10 days). No patients had phlegmasia caer-
ulea dolens. In eight cases (27.6%), DVT was associated
with pulmonary embolism found by CT scan. None of the
patients had a history of malignancy or signs of malignant
disease at CT scan.
Diagnosis was confirmed by DUS scan in 24 cases or by
thoracoabdominal-pelvic CT angiography scan in 26, or
both. Three patients did not have preoperative CT angiog-
raphy owing to pregnancy in two cases (operation was done
on the basis of DUS data only in 1 and after magnetic
resonance angiography in 1) and to renal insufficiency due
to Cacchi and Ricci disease in one case (DUS scan only).
Only three patients had preoperative phlebography (all
before 1997).
All patients had left femoroiliac DVT: the left common
tenosis of the left common iliac vein. A, Computed
iliac vein with proximal thrombosis (black arrow) and
raphy after left iliofemoral surgical thrombectomy shows
esence of residual clot within the vein. C, Completion
s left femoroiliac and inferior vena cava thrombectomy
puted tomography angiography (CTA) scan at the level
cava, acute thrombosis can be diagnosed due to parietal
ctomy through bilateral common femoral vein approach
nce of adherent clot. D, Completion angiography after







presefemoral and external iliac veins were always involved and
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popliteal, and femoral veins were also thrombosed in all
cases but one, who had only common femoral, external,
and common iliac veins thrombosis. The right common
iliac vein was thrombosed in two patients, including one
chronic thrombosis (history of right femoroiliac DVTmed-
ically treated). The IVC was involved in seven patients,
including two with juxtarenal IVC thrombosis. The patient
who had had previous IVC clip placement had acute left
femoroiliac and IVC thrombosis, with no clot above the
clip (Fig 2). A CT scan also showed left ovarian and renal
vein thrombosis in two patients: one had no IVC throm-
bosis and one had IVC thrombosis and nutcracker syn-
drome. In all, 151 venous segments were thrombosed, with
a median of five segments per patients (range, 2-7 seg-
ments). The CTA scan found a tight stenosis at the iliocaval
junction in 14 patients (48.3%; Fig 1, A). Two patients with
a history of DVT had chronic complete left common iliac
vein thrombosis (Fig 3, A), and one had occlusion due to
retroperitoneal fibrosis.5 In one patient, the left external
iliac vein was compressed by the left internal iliac artery.
Surgical technique. The procedure has already been
described,8 but the main steps are summarized.
All procedures were performed under general anesthe-
sia. Before surgery, the patient was cautiously moved and
Table I. Summary of the results of thrombophilia testing
Patient, sex Age, y Proth
Female 25 F II  F V Leyden
Male 46 F V Leyden, hyperhomocystein
Female 21 F V Leyden
Female 21 antiphospholipid antibodies
Female 38 F II  F V Leyden
Female 19 F V Leyden
Female 39 F V Leyden
Male 36 F V Leyden, hyperhomocystein
Female 67 F II  F V Leyden
Male 46 F II Leyden
F II, Factor II Leyden mutation; F V Leyden: factor V Leyden mutation.
Fig 3. Acute left femoroiliac deep vein thrombosis in a
Computed tomography angiography scan shows a tigh
without parietal enhancement. Ascending collateral path
bectomy through left common femoral vein approach,
transversal collateral pathways are seen. Recanalization
catheter. C, Angiography shows the result after angioplashaved to avoid clot fragmentation and migration thatcould cause pulmonary embolism. Prophylactic antibiotics
were given, and a cell saver device was always used.
Once the common femoral vein was approached, the
anesthesiologist was asked to use a positive end-expiratory
pressure (PEEP) of 10 cm H2O during the entire throm-
bectomy time to prevent pulmonary embolism. A intrave-
nous heparin bolus of 50UI/kgwas given if the patient was
already being treated with intravenous heparin; if not being
treated, then 100 UI/kg was given.
A 1.5-cm-long venotomy was performed at saphe-
nofemoral junction. Thrombectomy was performed using a
large Fogarty catheter, then associated with a Vollmar ring
(Aesculap, San Jose, Calif), until no more clots came back.
Calf, popliteal, and femoral vein thrombectomy was per-
formed without using any endovenous instrumentation by
a sturdy massage of the limb and the thigh. Thrombectomy
of the great saphenous vein was done as well, and then the
vein was sectioned 10 cm below the saphenofemoral junc-
tion.
The venotomy was closed using a 6-0 polypropylene
running suture; to prevent stricture, this was tied only after
all the veins were unclamped. In case of IVC involvement,
thrombectomy was performed using a right subcostal ap-
proach before the extremity thrombectomy.
A sheath was then introduced through the great saphe-
correlation with other underlying causes
otic state Other underlying cause
Postpartum





, and antiphospholipid antibodies
ent with chronic left common iliac vein thrombosis. A,
osis of the whole left common iliac vein (black arrow)
are visible. B, In this angiography after venous throm-
left common iliac vein is occluded and ascending and








wasnous vein and completion iliocavography was performed
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lesion was found (stenosis, occlusion, or residual adherent
clot), the vein was catheterized with a 0.035-in guidewire
and angioplasty was performed, generally using 12-mm-
diameter balloon. Self-expanding stents (Wallstent, Boston
Scientific-Schneider, Minneapolis, Minn) were deployed
protruding into the IVC and then dilated with a 15-mm
balloon before completion angiography (Fig 1, C; Fig 2, D;
Fig 3, C; Fig 4, C and D). The AVF was then performed
with an end-to-side anastomosis between the superficial
femoral artery and the great saphenous vein or with a 5-mm
polytetrafluoroethylene graft if the vein was unsuitable.
A bilateral elastic stocking was placed, and the intrave-
nous heparin infusion was continued. As soon as the patient
was awake, active mobilization was performed. We asked
the patient to begin walking from day 1. Long-term anti-
coagulation with fluindione was started the first postoper-
ative day and continued for at least 6 months, and the AVF
was surgically closed at 6 weeks.
Follow-up. Angiography was always performed at
during AVF closure at 6 weeks. Patients were scheduled for
clinical examination and DUS scanning at 1, 3, and 6
months, and then each year thereafter. The venous clinical
severity score (VCSS) and venous disability score (VDS)9
were evaluated during the follow-up to assess clinical re-
sults. In case of clinical recurrence of the symptoms or of
restenosis on color Doppler US (50% in-stent restenosis
or inflow obstruction is considered significant), transfemo-
ral percutaneous venography was performed. Valvular in-
competence was defined by DUS scan evaluation as reflux
Fig 4. Acute left femoral-external iliac deep venous thrombosis.
A, Arteriography. B, Iliocavography after venous thrombectomy
shows a major compression of the distal end of the left external iliac
vein. C, Face iliocavography after stenting. D, Profile iliocavogra-
phy after stenting.of 0.5-second duration during a Valsalva maneuveragainst a 40-mm Hg column with the patient in an erect
position. Severity of the reflux was assessed according to
Kistner et al10 phlebographic grading.
Statistical analysis. Primary, assisted primary, and
secondary patency rates were calculated using survival anal-
ysis with the life-table method from the date of stenting.
Nonparametric tests were used, with the Mann-WhitneyU
test for continuous data and the Fisher exact test for cate-
goric data when comparing the two groups of patients.
RESULTS
Four patients did not have angiography or stenting
during surgical thrombectomy, the first two cases, which
were both stented percutaneously before discharge, and the
two pregnant women. One had rethrombosis at day 1 and
had iterative thrombectomy, angiography, and stenting5;
the other underwent stenting after delivery. Iliocavography
found obstructive lesions in all patients: May-Thurner syn-
drome in 22 (Fig 1, B), common iliac occlusion in 3 (2
chronic lesions [Fig 3, B] and 1 retroperitoneal fibrosis),
residual clot in 3 (Fig 2, C), and compression of the
external iliac vein by the internal iliac artery in 1 (Fig 4, A
and B).
Balloon-expandable stents were used in two patients,
the first patient and a pregnant woman.5 In this last case,
this stent was chosen to decrease irradiation (10 seconds for
angiography before and after stent deployment). All other
stents were self-expanding Wallstent. Six patients received
two stents. The median length of stented vein was 60 mm
(range, 30-120 mm) with a median 16-mm diameter
(range, 12-16 mm). All stents but the two balloon-expand-
able stents protruded into the IVC. No stent extended
below the inguinal ligament.
During the same procedure, a JJ catheter was inserted
for left ureteral dilatation due to retroperitoneal fibrosis in
one patient, and a patient who had left arm traumatic
amputation a few days before had surgical redo of the
stump. In addition, the patient with infrarenal IVC, left
ovarian, and left renal vein thrombosis with a nutcracker
syndrome had left renal vein thrombectomy and transposi-
tion during IVC thrombectomy. The patient who had an
IVC clip was treated by a left femoral approach and throm-
boaspiration of the IVC with an 8F guiding catheter (Fig 2).
No procedural complications occurred, but four pa-
tients (13.8%) had early postoperative complications after
stenting. One patient with history of previous left femo-
roiliac DVT had rethrombosis at day 1. Iterative thrombec-
tomy was performed with endophlebectomy of the com-
mon femoral vein and stenting of the entire external iliac
vein. The proximal external iliac vein ruptured and was
ligated, leading to complete iliac rethrombosis (no covered
stent was available at this time). In the patient who had
previous iliocaval thrombectomy and IVC clip, the pros-
thetic AVF and the whole left iliac vein thrombosed at day
4, but the thrombectomized right iliac veins and the IVC
remained patent. The AVFs thrombosed postoperatively in
two patients; both had patent veins at DUS scan when
discharged, but one had rethrombosis at day 15.
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thrombectomy needed a blood transfusion. A blood trans-
fusion was needed perioperatively or postoperatively in six
patients (20.7%): the patient who had external iliac vein
rupture, along with four who had IVC thrombectomy and
one who had iterative iliofemoral thrombectomy.
All patients were discharged with fluindione therapy
and elastic stockings. The median length of stay was 8 days
(range, 5-22 days).
Median follow-up was 63 months (range, 2-137
months). No patients died or had pulmonary embolism
during the entire follow-up. At 6 weeks, 26 AVFs were
closed surgically without complications, except in the preg-
nant patients, which were closed postpartum. Originally,
30 AVFs were constructed (one bilateral), but three oc-
cluded 1 month and one occluded at 2 months in a
pregnant patient. Venous complications occurred during
follow-up in three patients. The pregnant patient who had
a balloon-expandable stent had rethrombosis 2 months
later (seventh month of pregnancy) due to stent crushing.5
A Palma procedure was performed 6 months after delivery,
which was still patent 66 months later. Two other patients
needed iterative stenting for proximal restenosis at 2 and 4
months, respectively.
Primary patency rates were 89.7% at 1 month and
78.9% at 12 and 60 months (Fig 5). Assisted primary and
secondary patency rates were 89.7% at 1 month and 86.1%
at 12 and 60 months. At the end of follow-up, the median
VCSS was 3 (range, 1-12) and VDS was 1 (range, 0-2) but
were lower in patients with a patent iliocaval segment
(Table II). In addition, DUS examination found signifi-
cantly less obstruction on the infrainguinal veins in patients
with a patent iliocaval segment (1 case only, 4%) than in
Fig 5. Primary, assisted-primary, and secondary patency rates af-
ter venous thrombectomy and stenting of 24 patients who had
venous thrombectomy (intention to treat). Standard error was
10% at 48months for primary patency, at 69months for assisted-
primary and secondary patency (the curves are represented as
dotted lines when SEM is 10%).patients who had iliac rethrombosis (50%; P  .0421; TableII). Reflux was present in all patients who had iliac rethrom-
bosis compared with six of the 25 patients (24%) with
patent iliocaval segments (P  .00884; Table II). Of these,
three had grade III reflux: one had a thrombectomy at day
10, and one had undergone thrombectomy 24 years be-
fore.
DISCUSSION
Results of surgical venous thrombectomy have been
extensively reported and discussed. The results are good
when performed by trained teams,3-4,11-13 with mortality
rates of 0% to 1%, low morbidity rates, and good long-term
results for patency and valvular competence.3,11-12 More-
over, construction of an AVF was shown to reduce acute
rethrombosis14 and pulmonary embolism.15 It can be also
safely performed during pregnancy, as reported by Pillny
et al.16
One of the main concerns with this technique was the
risk of early rethrombosis. Juhan et al3 and Mickley et al4
demonstrated that this complication was mostly due to the
presence of stenotic lesions, whatever their cause, including
extrinsic compression, luminal webs, or residual clot. Mick-
ley et al4 reported that such stenotic lesions led to 73% of
rethrombosis if left untreated. In our previously reported
experience,3 it occurred in 7% of the cases without stenosis,
in 26% of those with mild stenosis, and in 56% of cases of
tight stenosis. In such cases, reports recommended repeat
thrombectomy (despite the high risk of iterative thrombo-
sis)3 or to perform a bypass, the Palma procedure being the
technique of choice owing to its relatively low invasiveness
compared with the other surgical possibilities.
Stenting has documented safety and effectiveness in the
treatment of chronic lesions.17,18 The goal of stenting
during interventional procedures for DVT is to treat the
lesions that compromise patency while avoiding a long and
complex concomitant procedure. This endovascular proce-
dure can be performed during surgical thrombectomy and
usually requires about 10 minutes to be completed. In
contrast, Wohlgemuth et al19 reported stenting at a mean
Table II. Results of the thrombectomy on infrainguinal









Obstruction, No. 1 2 .0421
Reflux, No. 6 4 .00884
Grade I 1 0
Grade II 2 0
Grade III 3 3
Grade IV 0 1
Venous scores, mean (range)
VDS 3 (2-8) 8 (7-12) .006106
VCSS 0 (0-2) 2 (1-2) .002335
VDS, Venous disability score; VCSS, Venous clinical severity score.4.1 months after thrombectomy during AVF surgical clo-
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does not protect as well as concomitant stenting against
early rethrombosis, and this delay before AVF closure is too
long. Indeed, a long-standing AVF can be associated with
distal common femoral vein stenosis, as Wohlgemuth et
al19 noted: 67% of stenoses were located immediately prox-
imal to the origin of the AVF. This is why AVF closure
should be performed at 6 weeks, experimental studies
having shown that vein reendothelialization is nearly com-
plete 4 weeks.20 Technical tips for stenting were already
discussed in a previous report.17
Although AVF construction was shown to be effective
during venous thrombectomy,11 some authors have re-
stricted its use since the introduction of contemporary
stenting during the surgical procedure,13,21 arguing that
there should be no more obstructive lesions after stent
implantation. We agree, but the goal of the AVF is also to
keep the vein patent during the time needed for re-
endothelialization of the thrombectomized vein and endo-
thelialization of the stent.Moreover, in our experience, two
patients needed iterative stenting during AVF closure, and
it could be argued that the AVF protected them from
rethrombosis.
The results of surgical thrombectomy associated with
stenting show that this approach can provide the same
postoperative results as venous thrombectomy in patients
without obstructive lesions. In our experience, rethrombo-
ses occurred at least in two patients who were not the best
candidates for the technique (iterative thrombectomy,
thrombectomy on diseased veins after previous iliofemoral
DVT). The last case remains unexplained, because the
patient refused an iterative procedure after AVF thrombosis
as well as after vein rethrombosis 13 days later.
Mortality and morbidity with this approach were very
low compared with results reported by Mewissen et al22
using thrombolysis, with major bleeding, 11%; major neu-
Table III. Comparison of the results of venous thromboly
venous thrombosis
First author Technique No. Technical succe
O’Sullivan23 TL 19 
Mewissen22 TL 144 88 50% of ly
Bjarnason24 TL 86 
Comerota25 TL 58 84 
Patel27 TL 10 100
AbuRahma28 TL 10 90
Vedantham26 MT  TL 14 100
Kwak29 MT  TL 22 96 
Mickley4* ST 8 95 
Wohlgemuth19* ST 35 97 
Schwarzbach30* ST 20 100 
Husmann31 ST 11 100 
Hartung17* ST 29 100 
SP, Secondary patency rate; ST, surgical thrombectomy and arteriovenous fi
*Intention to treat.rologic complications, 0.4%; pulmonary embolism, 1%, anddeath, 0.4%. Moreover transfusion was not needed in pa-
tients without a history of ipsilateral iliofemoral DVT and
without IVC involvement. Surgical thrombectomy also
provided a high technical success rate (always 95% in the
literature), which overtakes those of thrombolysis (Table
II),22-29 but patency rates at 1 year are similar for both
approaches (Table III).22-31 Various contraindications
limit the applicability of percutaneous techniques, which
was 75% in our previously published experience,3 and 38%
in this report. Contraindications to the adjunctive stenting
are sepsis (if not also a contraindication to venous throm-
bectomy) and pregnancy. In pregnant women, stenting
should be performed after delivery; but in case of early
rethrombosis, the use of a self-expanding stent should be
considered despite the need for longer irradiation time.
A major issue with this approach is late results. One
thrombosis occurred at 2 months and was linked with the
use of a balloon-expandable stent in a pregnant patient,
confirming, if needed, that self-expanding stents represent
so far the best technology to treat venous lesions. Two early
restenosis occurred andwere treated by iterative stenting. It
seems that they were due to the delivery of 40-mm stents
that were too short and did not cover the whole lesions.
It is noteworthy that no other complications influenc-
ing patency have occurred so far after the fourth postoper-
ative month. With a median of 63 months, we report the
longest follow-up after such procedures, to our knowledge.
Our results are consistent with those of the literature re-
garding surgical venous thrombectomy with stenting of
iliac obstruction4,19,30-31 and are comparable with those
we had in a former report,3 including patients with or
without obstructive lesions. It is not possible to compare
these long-term results with those of thrombolysis because
all authors but one report follow-up of only 12
months.23-28 Kwak et al,29 with a mean 21 months of
follow-up, reported a 95% primary patency rate and 100%
nd venous thrombectomy for acute deep
Primary patency, %
Late SP, %At 12 months Late
Stent : 92
Stent: 53; Stent: 74
Stent: 75; Stent: 54
Stent: 71; Stent: 89
95 24 mo: 95 24 mo: 100
73 24 mo: 73 24 mo: 82
76 48 mo: 66 48 mo: 69
21 mo: 80 21 mo: 90
82 22 mo: 82 22 mo: 91
79 60 mo: 79 60 mo: 86
TL, thrombolysis; MT, mechanical thrombectomy.sis a
ss, %
sis 
stula;secondary patency rate at 24 months. Furthermore, com-
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cantly higher in patients whose iliocaval segment remained
patent. These data are confirmed by venous scores that
show that these patients were not disabled, or only mini-
mally so. On the other, hand all patients who had rethrom-
bosis had reflux grade III or IV and had higher venous
scores.
CONCLUSION
Stenting provides considerably improved results with
good long-term patency rates in patients with underlying
stenotic lesions who have surgical thrombectomy with con-
struction of an AVF. It also avoids most of the rethrombo-
ses and post-thrombotic syndrome. These data, if con-
firmed by larger studies, should lead to reconsideration of
surgical thrombectomy to treat acute DVT with iliocaval
extension.
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